Measure syringe break-loose and glide force with a texture analyzer per ISO 7886-1 and ISO 11040-4. KHT TA-30 protocol for prefilled syringes and auto-injectors.
A syringe glide force test measures the steady-state axial force required to depress the plunger of a syringe, performed on a texture analyzer per ISO 7886-1:2017 for sterile hypodermic syringes and ISO 11040-4 for glass prefilled syringes. The test reports two distinct force values — break-loose force (F1), the peak force to initiate plunger movement from rest (typically 4–20 N), and glide force (F2), the steady-state force during continuous depression (typically 3–15 N).
Both values directly impact patient dosing accuracy and auto-injector reliability, which is why every sterile-syringe release spec and every combination drug-device filing includes F1/F2 acceptance criteria. The KHT TA-30 Pharmaceutical Texture Analyzer performs this test with a dedicated syringe activation rig, 500 N load cell, 100 mm/s compression speed per ISO 7886-1, and 21 CFR Part 11–compliant data capture as standard.
Three syringe subtypes drive most pharmaceutical force testing. Standard sterile hypodermic syringes (Luer-lok, Luer-slip, disposable) are regulated by ISO 7886-1:2017. Glass prefilled syringes (PFS) used for biologics, vaccines, and parenteral small molecules are regulated by ISO 11040-4:2015 — the added complication being that PFS sit at 2–8 °C for months before use, during which silicone oil can migrate and dry, raising F1 significantly. Auto-injectors and pen injectors are regulated by ISO 11608-1:2022.
All three subtypes use the same core instrument — a texture analyzer with a low-compliance frame, 500 N load cell, 100 mm/s capable crosshead, and 0.001 mm displacement resolution. The force-testing requirement is not optional: FDA's 21 CFR 211.165 requires release testing of every finished drug product batch, and sterile-syringe monographs in USP, EP, and JP all reference ISO 7886-1 or its regional equivalents.
Break-loose force (F1) is the peak force recorded at the very start of plunger travel — typically within the first 0.5–2 mm of compression. Physically, F1 overcomes static friction between the rubber stopper and the glass or polymer barrel. Elevated F1 almost always indicates a siliconisation problem: insufficient silicone oil or oil that has dried or migrated during storage.
Glide force (F2) is the steady-state force sustained after break-loose, over the bulk of plunger travel (10–90 % of full stroke). Physically, F2 is kinetic friction plus fluid viscous drag through the needle. Elevated F2 typically indicates a barrel dimensional issue or insufficient bulk siliconisation.
| Observation | Likely Root Cause |
|---|---|
| F1 high, F2 normal | Dried / migrated silicone at stopper contact zone |
| F1 normal, F2 high | Insufficient bulk silicone or barrel out-of-tolerance |
| Both high | Under-siliconised batch; reject |
| Both acceptable, F2 rising over shelf life | Silicone migration toward needle end — stability flag |
ISO 7886-1:2017 — Sterile hypodermic syringes for single use. Key requirements: test speed 100 mm/min (1.67 mm/s), sample conditioning 23 °C ± 2 °C for ≥ 3 hours, minimum 3 syringes per batch. F1 is peak force during first 5 mm; F2 is mean force across middle 80 % of stroke.
ISO 11040-4:2015 — Glass prefilled syringes. Adds stability testing at 5 °C, 25 °C/60 % RH, and 40 °C/75 % RH per ICH Q1A, with F1 and F2 reported at each timepoint. ISO 11608-1:2022 covers auto-injectors, measuring activation force at the trigger button and duration of injection.
Setup is straightforward once the daily calibration is complete. Required hardware: KHT TA-30 with 500 N load cell, syringe activation rig (adjustable barrel clamp for 1/3/5/10/20 mL sizes), plunger compression tip (flat, 10 mm diameter), and optional temperature-controlled chamber for stability protocols.
Recommended test parameters per ISO 7886-1: speed 100 mm/min (1.67 mm/s), trigger force 0.05 N, full plunger stroke, 500 Hz data acquisition, F1 window at first 5 mm, F2 window at 10–90 % of remaining stroke.
Typical commercial acceptance criteria, derived from ISO 7886-1 guidance and published literature. Stability-indicating F1/F2 data is submitted in the CMC section of an IND or NDA and in post-approval batch release records.
The KHT TA-30 writes every test to a 21 CFR Part 11–compliant audit trail, captures electronic signatures, and exports validated PDF reports — required for FDA, EMA, and PMDA submissions. The IQ/OQ/PQ validation package ships with the instrument and is revised annually at no additional charge.
| Syringe Type | F1 (Break-Loose) Typical Spec | F2 (Glide) Typical Spec |
|---|---|---|
| 1 mL insulin syringe | ≤ 10 N | ≤ 6 N |
| 3 mL standard disposable | ≤ 15 N | ≤ 10 N |
| 5–10 mL standard | ≤ 20 N | ≤ 15 N |
| 1 mL prefilled (biologic) | ≤ 20 N | ≤ 15 N |
| 1 mL prefilled (vaccine, aq) | ≤ 10 N | ≤ 6 N |
| Auto-injector activation | Per device spec (15–50 N) | n/a |
| Standard | Scope | KHT TA-30 Coverage |
|---|---|---|
| ISO 7886-1:2017 | Sterile hypodermic syringes — plunger force test | Meets — 100 mm/min speed, F1/F2 auto-detection |
| ISO 11040-4:2015 | Glass prefilled syringes — functional performance | Meets — stability-compatible, dedicated rig |
| ISO 11608-1:2022 | Needle-based injection systems (auto-injectors) | Meets — trigger-force detection, duration logging |
| ISO 7864 | Sterile hypodermic needles | Meets with needle-penetration fixture |
| 21 CFR Part 11 | Electronic records and signatures | Standard — audit trail + e-sig built in |
| EMA Annex 11 | EU equivalent of Part 11 | Standard |
| USP <1> | Injections — general chapter | Supports QC workflows |
| Parameter | Typical Range | Acceptance Criterion (example) | Notes |
|---|---|---|---|
| Break-loose force (F1) | 4–20 N | ≤ 15 N | Peak force, first 5 mm |
| Glide force (F2) | 3–15 N | ≤ 10 N | Mean force, 10–90 % stroke |
| Dead-volume residual | 0.01–0.1 mL | Per device spec | Post-full-stroke drug retention |
| Auto-injector activation | 15–50 N | Per device spec | Trigger-button force |
| Injection duration | 1–15 s | Per device spec | Auto-injector time-to-empty |
Common questions about ISO 7886 syringe force testing with a pharmaceutical texture analyzer.
Transparent $8,000–$13,000 pricing. Every quote includes the IQ/OQ/PQ validation package, 30+ method library, 21 CFR Part 11 software, standard probe set, and 2-year warranty. Response within 24 hours; engineering SLA within 48 hours.
© 2026 KHT Pharmaceutical Texture Analyzer | pharmaceuticaltextureanalyzer.com
